Brain & Spinal Cord Tumors in Children | NYU Langone Health
Specialists at Hassenfeld Children's Hospital at NYU Langone diagnose and treat childhood brain and spinal cord tumors.
Brain & Spine Care | NYU Langone Health
NYU Langone neurologists and neurosurgeons provide advanced nonsurgical and surgical care for the brain and spine.
Brain & Spine Care Locations | NYU Langone Health
NYU Langone offers convenient locations for brain and spine care in New York City and on Long Island.
Brain & Spine Tumor Center | NYU Langone Health
At NYU Langone’s Brain and Spine Tumor Center, cancer care experts support our neurosurgeons, ensuring you receive the best treatment.
Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease
The current biomarker classification system (i.e., the ATN model) may not fully account for racial disparity and can’t explain the increased prevalence in blacks of both AD and vascular risk factors for AD such as diabetes and hypertension when compared to whites. Postmortem studies suggest that loss of LC neurons better predicts severity of AD clinical symptoms than Aß/neurofibrillary tangle pathology in any other cortical/subcortical brain region. Our decade-long studies in humans have demonstrated a special vulnerability of LC to aging and stress. Further, our preliminary data in black and white subjects reveals that the decline rate of LC neurons is much faster in blacks starting in the mid-30s, particularly in black males. We now aim to test the hypothesis that cumulative exposure to socioeconomic disadvantage and racial discrimination may cause long-lasting changes in LC function followed by LC neuronal loss, which would explain the different AD phenotypical presentation among blacks; by asking120 cognitively normal older adults (80 blacks and 40 whites) to perform clinical evaluation, cognitive measurement, biomarkers (ATN and vascular markers) assessment, stress and discrimination scale testing, and one [11C]MRB PET-MR scan to determine NET availability.
Brain Fog Following COVID-19 (SARS-COV-2 Infection)
The purpose of this study is to examine whether or not individuals who were previously diagnosed with SARS-CoV-2, or COVID-19, have greater cognitive and biomarker changes over five years than those individuals who did not have COVID-19. This is a prospective, observational, longitudinal cohort study (n=300) of the following groups: SARS-CoV-2 laboratory positive subjects who have new objective or subjective cognitive abnormalities within 12 months of SARS-CoV-2 infection (COVID+Cog+); SARS-CoV-2 laboratory positive subjects without new cognitive findings within 12 months of SARS-CoV-2 infection (COVID+Cog-); or SARS-CoV-2 negative subjects who are cognitively normal (Controls). Participants will have demographic and medical history collected, along with cognitive testing, blood testing, gait measurements, olfactory testing and a brain MRI. Participants will be tested every 12 months over the course of 5 years, and undergo a total of three brain MRIs. Each visit will last approximately 6 hours (interviews and cognitive testing) and each MRI is approximately 45 minutes. We are currently recruiting people who have never had a history of COVID-19 and who have never tested positive for SARS-CoV-2 or COVID-19.
Brain Injury & Concussion Rehabilitation | NYU Langone Health
The team at NYU Langone’s Rusk Rehabilitation provides inpatient and outpatient care for people after a brain injury or concussion.
Brain Tumors | NYU Langone Health
At NYU Langone’s Perlmutter Cancer Center, we treat adults with glioblastomas, gliomas, astrocytomas, meningiomas, and metastatic brain tumors.
Breast & Ovarian Cancer Screening | NYU Langone Health
At NYU Langone’s Perlmutter Cancer Center, we offer screening and special high-risk programs for breast and ovarian cancer.
Breast & Ovarian Cancer Screening | NYU Langone Health
At NYU Langone’s Perlmutter Cancer Center, we offer screening and special high-risk programs for breast and ovarian cancer.